- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-Muscle Invasive Bladder Neoplasms in United Kingdom
Total 7468 results
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerSpain, United Kingdom, Belgium
-
Weill Medical College of Cornell UniversityCompletedProstate Cancer | Bladder CancerUnited States
-
Hollister IncorporatedParexel; Technomics ResearchRecruiting
-
Vanderbilt UniversityElement DiagnosticsCompletedBladder Cancer, BiomarkersUnited States
-
University of OxfordMedical Research CouncilCompletedMultiple System Atrophy | Gait Disorders, Neurologic | Bladder, Neurogenic | Autonomic Failure | Postural HypotensionUnited Kingdom
-
PfizerTerminatedAdvanced Non-Hematologic MalignanciesUnited States, United Kingdom
-
Autolus LimitedRecruitingRelapsed or Refractory B Cell Acute Lymphoblastic Leukemia | Relapsed or Refractory B Cell Non-Hodgkin LymphomaUnited Kingdom
-
NYU Langone HealthCompletedProstate Cancer | Bladder CancerUnited States
-
European Organisation for Research and Treatment...UnknownNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIGermany, Belgium, United Kingdom, Switzerland
-
Memorial Sloan Kettering Cancer CenterCompletedBladder Cancer | High Risk SuperficialUnited States
-
NRG OncologyNational Cancer Institute (NCI)TerminatedStage III Bladder Cancer | Stage IV Bladder CancerCanada, United States, Israel
-
Medical University of South CarolinaTerminatedBladder CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheTerminated
-
AbbVieRecruitingNon Small Cell Lung CancerCanada, United Kingdom
-
Baylor College of MedicineM.D. Anderson Cancer Center; University of Rochester; Laval UniversityCompleted
-
University of PennsylvaniaCompletedGastric Cancer | Bladder CancerUnited States
-
M.D. Anderson Cancer CenterTerminatedProstate Cancer | Bladder Cancer | Genitourinary CancerUnited States
-
AstraZenecaCompletedNon-Small Cell Lung Cancer NSCLCUnited Kingdom
-
Jonsson Comprehensive Cancer CenterWithdrawnInfiltrating Bladder Urothelial CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteAmgenActive, not recruitingBreast Cancer | Invasive Breast Carcinoma | Invasive Ductal Breast Carcinoma | Ductal CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedBladder Carcinoma | Recurrent Bladder CarcinomaUnited States
-
Northwell HealthFox Chase Cancer CenterRecruitingPatient Engagement | Bladder Cancer | Patient Empowerment | Ileal ConduitUnited States
-
Endo PharmaceuticalsTerminated
-
Celldex TherapeuticsTerminated
-
Debiopharm International SASyneos HealthTerminatedNon-small Cell Lung CancerSpain, France, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaTerminatedBladder Cancer | Carcinoma in Situ of BladderUnited States
-
Societe Internationale d'Oncologie PediatriqueCompletedSarcoma | Childhood Malignant Fibrous Histiocytoma of BoneUnited Kingdom
-
CicloMed LLCCompleted
-
University of Michigan Rogel Cancer CenterTerminatedProstate Cancer | Bladder Cancer | Urothelial Carcinoma | Non-Small-Cell Lung CarcinomaUnited States
-
Dana-Farber Cancer InstitutePfizerCompletedBreast Cancer Stage IV | Unresectable Locally Advanced Invasive Breast Cancer | Metastatic Invasive Breast CancerUnited States
-
University of MichiganCompletedBladder Cancer | Transitional Cell Carcinoma of the BladderUnited States
-
Autolus LimitedRecruitingAnaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | T Cell Non-Hodgkin Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedUnited Kingdom, Spain
-
Scotland and Newcastle Lymphoma GroupUnknown
-
Bioven EuropeTerminatedCarcinoma, Non-Small-Cell LungUnited Kingdom
-
Astex Pharmaceuticals, Inc.TerminatedProstate Cancer | Non-Hodgkins LymphomaUnited Kingdom, United States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedBladder CancerUnited States, Canada
-
University of Colorado, DenverRutgers Cancer Institute of New JerseyTerminatedBladder CarcinomaUnited States
-
Taris Biomedical LLCBristol-Myers SquibbTerminatedBladder Cancer TNM Staging Primary Tumor (T) T2 | Bladder Cancer TNM Staging Primary Tumor (T) T2A | Bladder Cancer TNM Staging Primary Tumor (T) T2B | Bladder Cancer TNM Staging Primary Tumor (T) T3 | Bladder Cancer TNM Staging Primary Tumor (T) T3A | Bladder Cancer TNM Staging Primary Tumor... and other conditionsUnited States
-
University of Kansas Medical CenterUnknown
-
PhotocureKARL STORZ Endoscopy-America, Inc.Completed
-
Spectrum Pharmaceuticals, IncAllerganTerminatedBladder CancerUnited States, Poland, Czechia, Slovakia
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid CancersUnited States, United Kingdom
-
xCuresTerminatedTransitional Cell Carcinoma | Bladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | FGFR2 Gene Mutation | FGFR3 Gene Mutation | FGFR2 Amplification | Bladder Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Refractory Bladder Carcinoma | Refractory Bladder Urothelial Carcinoma and other conditionsUnited States
-
PhotocureCatalyst Pharmaceutical ResearchRecruiting
-
Hoffmann-La RocheCompletedBladder CancerUnited States, France, Belgium, Korea, Republic of, United Kingdom, Czechia, Austria, Canada, Denmark, Greece, Italy, Netherlands, Portugal, Slovenia, Spain, Sweden, Turkey, Poland, Hungary, Switzerland, Japan, Taiwan, Australia, Norway, Germa... and more
-
University of Kansas Medical CenterVikor ScientificNot yet recruitingUrinary Tract Infections | Bladder CancerUnited States
-
CG Oncology, Inc.CompletedSafety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure (BOND2)Bladder CancerUnited States
-
State University of New York - Upstate Medical...CompletedBladder Cancer | HematuriaUnited States
-
MDx HealthUnknownBladder Cancer | HematuriaUnited States